Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: Is azathioprine a contributory factor?

Journal of Heart and Lung Transplantation

Volumn 18, Issue 6, 1999, Pages 607-610

  Delgado, J ^a   Munoz De Bustillo E ^a   Ibarrola, C ^a   Colina, F ^a   Morales, J M ^a   Rodriguez, E ^a   Aguado, J M ^a   Fuertes, A ^a   Gomez, M A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; OKT 3; PREDNISONE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CHOLESTATIC HEPATITIS; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TOXICITY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AZATHIOPRINE; CHOLESTASIS, INTRAHEPATIC; FATAL OUTCOME; HEART TRANSPLANTATION; HEPATITIS C; HEPATITIS, TOXIC; HUMANS; HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER REGENERATION; MALE; MIDDLE AGED; PORTAL VEIN;

EID: 0345188656     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00019-9     Document Type: Article

References (5)

1. Cadranel J.F., Grippon P., Lunel F., et al. Chronic liver disfunction in heart transplant recipients, with special reference to viral B, C, and non-A, non-B, non-C hepatitis. Transplantation. 52:1991;645-650.
2. Fang J.W.S., Wright T.L., Lau J.Y.N. Fibrosing cholestatic hepatitis in patients with HIV and hepatitis B. Lancet. 342:1993;1175.
3. Lam P.W.Y., Wachs M.E., Somberg K.A., et al. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation. 61:1996;378-381.
4. Zylberberg H., Carnot F., Mamzer M.F., et al. Hepatitis C virus related fibrosing cholestatic hepatitis after renal transplantation. Transplantation. 63:1997;158-160.
5. Lim H., Lau G., Davis G., et al. Cholestatic hepatitis leading to hepatic failure in a patient with organ transmitted hepatitis C virus infection. Gastroenterology. 106:1994;248-251.